Dan Ollendorf
@dano-hta.bsky.social
370 followers
94 following
38 posts
Clin epi / health economics, focus on the evidence and science, fan of sanity
Posts
Media
Videos
Starter Packs
Reposted by Dan Ollendorf
Reposted by Dan Ollendorf
Reposted by Dan Ollendorf
Reposted by Dan Ollendorf
Reposted by Dan Ollendorf
Reposted by Dan Ollendorf
Dan Ollendorf
@dano-hta.bsky.social
· Aug 4
Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price Negotiations | Health Affairs Journal
The Centers for Medicare and Medicaid Services (CMS) can now negotiate the prices of a set of drugs that represent significant Medicare expenditures. The long-term success of negotiations will depend ...
www.healthaffairs.org
Dan Ollendorf
@dano-hta.bsky.social
· Aug 4
Dan Ollendorf
@dano-hta.bsky.social
· Aug 4
Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price Negotiations | Health Affairs Journal
The Centers for Medicare and Medicaid Services (CMS) can now negotiate the prices of a set of drugs that represent significant Medicare expenditures. The long-term success of negotiations will depend ...
www.healthaffairs.org
Dan Ollendorf
@dano-hta.bsky.social
· Aug 4
Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price Negotiations | Health Affairs Journal
The Centers for Medicare and Medicaid Services (CMS) can now negotiate the prices of a set of drugs that represent significant Medicare expenditures. The long-term success of negotiations will depend ...
www.healthaffairs.org
Reposted by Dan Ollendorf
Reposted by Dan Ollendorf
CEVR
@tuftscevr.bsky.social
· Jul 18
Health Economics and Outcomes Research (HEOR) Certificate Program - Tufts CTSI
Overview The Tufts University Graduate School of Biomedical Sciences (GSBS) Clinical and Translational Science (CTS) Graduate Program is delighted to offer an accredited Certificate Program in Health ...
tinyurl.com
Reposted by Dan Ollendorf
Richard Ferro, MD
@richferro.com
· Jul 8
Dan Ollendorf
@dano-hta.bsky.social
· Jul 2
CEVR
@tuftscevr.bsky.social
· Jul 2
Frontiers | Value attribution for oncology combination regimens: going beyond frameworks to balance innovation, access, and affordability
Combination therapies are a mainstay in cancer treatment, but reimbursement access can be limited, owing to complexities around value assessment and pricing,...
tinyurl.com
Reposted by Dan Ollendorf
CEVR
@tuftscevr.bsky.social
· Jul 2
Frontiers | Value attribution for oncology combination regimens: going beyond frameworks to balance innovation, access, and affordability
Combination therapies are a mainstay in cancer treatment, but reimbursement access can be limited, owing to complexities around value assessment and pricing,...
tinyurl.com
Dan Ollendorf
@dano-hta.bsky.social
· Jun 10
Celebrating Ten Years of the international Decision Support Initiative
Over the last decade, iDSI has partnered with countries to develop evidence-informed priority-setting institutions and processes. Read our blog for a summary of key successes, challenges, and lessons ...
bit.ly